Integrated DNA Technologies Mark Behlke MD, PhD Chief Scientific Officer Ootemachi First Square Conference July 30, 2013 MBL/IDT Next Gen Sequencing Symposium Improved Reagents & Methods for Target Enrichment in Next Generation Sequencing
Aug 28, 2014
Integrated DNA Technologies
Mark Behlke MD, PhD Chief Scientific Officer
Ootemachi First Square Conference July 30, 2013
MBL/IDT Next Gen Sequencing Symposium
Improved Reagents & Methods for Target Enrichment in Next Generation Sequencing
General NGS Workflow
2
DNA DNA ShearingAdaptor and Barcode [opt] Attachment
Enrichment [optional] Template/Library Preparation
Sequencing Analysis
Why enrich?
Detecting rare variants requires enrichment + cost/time savings
3
1. Achieve many times greater coverage than with whole genome sequencing2. Multiplex many samples on 1 lane
Less cost per sampleMany samples analyzed in a single run
Enrichment Methods
4
Hybrid Capture Amplicon
PCRMicro droplet PCR
Haloplex™
AmpliSeq™ Panels
TruSeq™ Custom Amplicon
Comparing enrichment methods
5
Hybrid Capture Amplicon Enrichment
WorkflowMore complex
Slower (1-2 days)New fast protocol …
Less complexFast (< 1 day)
Cost Higher upfront costLower cost per sample
Lower upfront costHigher cost per sample
Problems Sequence / GC content bias Amplicon failuresSNPs in primer sites
Input DNA needed Med to High Low
Capture size 5 KB to Whole Exome5 KB to 1 MB
New whole exome available
ApplicationsVariant analysis
Gene expression / CNVSplice variantsTranslocations
Variant analysis
Two different approaches to capture probes
6
• Agilent or NimbleGen whole exome kits• Low quality, low yield oligo probes made on microarray chips• Advantage = cheap to make a million probes (capture >50 Mb)
• Perfect way to make whole exome sets• Disadvantage = low quality probes, cannot QC, no idea about individual
probe concentration• Variable capture efficiency between target loci, big “GC” bias effect• Difficult, slow and costly to change content
• IDT xGenTM LockdownTM Probes• High quality, high yield oligos made individually• Advantage = QC each oligo, measure and normalize yield prior to pooling• Improved capture efficiency between many loci• Disadvantage = higher price per probe (but high yield)
• Use for small focused sets or to spike into whole exome sets• Easy to change content just make another oligo and add to pool!• High yield makes it cheaper when running lots of samples
IDT UltramerTM synthesis: the key to xGenTM LockdownTM probes
7
• Ultramers = ultra long oligos made on a specialized synthesis platform with custom supports and its own synthesis cycle
• Highest possible coupling efficiency = long oligos can be made that otherwise could not be made. For 120mers, no need to purify!
• 60-200mers sold to customers (size limit is set by our ability to perform ESI MS QC); within IDT, we use 60-300mers in our gene synthesis group
UltramersTM can be made with high GC content (unlike arrays)
8
Calc. mass 37786.3 DaMeasured 37789.6 Da
BioGCGGCGAGCGGAGATCCGGGGCCTGCGCTGCGCACTCGAGCCTGGCGGGCCGGCACGGTGCGGGCCATGAGCGGGGCGGTGCCCCAGGACCTAGCGGTGAGTGGCGGCCGAGTCGGGCAC
ESI-MS trace of an xGENTM LockdownTM probe with 78% GC content
Two ways to use xGenTM LockdownTM Probes
9
1. Make your own small focused sets with 5-2000 KB coverage
2. Spike into whole exome array oligo sets to improve performance of products you may already be using
1. NimbleGen2. Agilent
Improve Agilent SureSelectTM – example from Foundation Medicine
10
• Custom Agilent SureSelectTM 1.1 Mbp capture array for Foundation Medicine• Prototype in development for oncology medical re-sequencing panel
• Problems seen with getting complete coverage of desired exons
• Spike in 1100 IDT xGenTM LockdownTM probes (5’-biotin, 120mers)• 135 Kbp coverage, duplicates what should already be in tiled array
• Sequence on Illumina HiSeq2000 platform
Foundation MedicineBoston, Massachusetts
Improve performance of whole exome capture kits (spike-in)
11
Foundation MedicineBoston, Massachusetts
Before supplementation with xGenTM LockdownTM probes
After supplementation with xGenTM LockdownTM Probes
Replace SureSelectTM with custom xGenTM LockdownTM Probe Library
12
Foundation MedicineBoston, Massachusetts
Results from Foundation Medicine comparing results of a large set of IDT xGenTM LockdownTM probes with a focused Agilent SureSelectTM set.
IDT xGEN: 100% >150x coverageAgilent: 80.7% >150x coverage
# Reads
IDT
Agilent
xGenTM LockdownTM Probes show less GC bias
13
Foundation MedicineBoston, Massachusetts
IDT
Agilent
Design of capture probes
14
xGenTM LockdownTM probes are high quality UltramerTM synthesis. Each oligo gets mass spec QC and is OD260 measured with quantity normalized.
SureSelectTM and other low quality array oligos need large overlaps. You cannot QC each oligo so you need to have high overlap to help ensure coverage.
Do mutations in target hurt capture efficiency?
15
• Short oligos can distinguish a single SNP site based on hybridization. Since the goal is to capture variants and detect these by sequencing, do we risk missing SNPs due to hybridization failure?
• Long 120mers, however, are very tolerant to mismatch
• How tolerant?
• Studied Tm of hybridization of a single 120mer bait oligo to different targets having 0-7 bases mismatch (either permissive G:T pairing or more disruptive T:T pairings)
• Also studied targets with 1, 3, or 7 base insertions (indels)
Design of 120mer Tm experiment
16
DTm with 1-7 base mismatches (SNPs)
17
Mismatches Tm oCMeasured
D Tm oCMismatch
Tm oCPredicted
0 85.7 -- 87.6
1 T-T 85.6 - 0.1 87.1
1 T-T 85.0 - 0.7 86.9
3 T-T 84.2 - 1.5 85.7
7 T-T 80.9 - 4.8 82.9
7 T-G 81.6 - 4.1 85.8
DTm with 1, 3, or 7 base insertions (indels)
18
Bulge Tm oCMeasured
D Tm oCMismatch
None 85.7 --
1 T 85.3 - 0.4
3 T 84.8 - 0.9
7 T 83.9 - 1.8
7 T + 7 T 82.3 - 3.4
7 C + 7 C 82.4 - 3.3
Conclusions from Tm studies
19
• 1-7 base mismatches had < 5oC DTm
• 1 or 2 1-7 base insertions had < 4oC DTm
• These small changes in Tm should not affect capture
• Thus use of 120mer capture probes is sufficient and should be effective in capturing targets even when a significant level of polymorphism is present
Blocking oligos – another critical component of enrichment/capture
20
Two classes of blocking oligos are needed:
1) Cot1 DNA = Alu, LINE repeat elements
2) linkers/adaptors
Importance of using Human Cot1 blocking DNA
21
Example: Merkel Cell Polyomavirus study:
Capture hyb with 1 ug Cot1 DNA Total Reads 7,603,264 Capture specific 520,304 Match to virus 6.8%
Capture hyb without Cot1 DNA Total Reads 2,313,487 Capture specific 57,967 Match to virus 2.5%
New product: xGen® Blocking Oligos
22
Two classes of blocking oligos are needed:
1) Cot1 DNA = Alu, Line repeat elements
2) linkers/adaptors
A new generation of blockers to improve this step in the enrichment process
New xGen® Blocking Oligos
23
In early experiment, simple DNA blockers proved to be effective. By adding excess blocker, ‘mass action’ drives hybridization in favor of the blocker-adaptor instead of the undesired blocker-blocker pairing.
However, in most experiments done today, either one or both adaptors contains an “index” or “bar code” sequence of 6-8 bases. Highly multiplexed experiments now have mismatched blockers binding to adaptors, and on-target capture rates dropped.
IDT offers a new solution to this problem: xGen® Blocking Oligos .The new generation of blockers incorporates Inosine bases to pair with index domains, so a single blocker can be used with all index variants. Further, the new blockers have additional improvements which increase effectiveness and give higher on-target capture rates.
Example of Inosine incorporation in one specific adaptor
24
TruSeq P7 Index 6 x I (also have 8 x I) CAAGCAGAAGACGGCATACGAGAT(IIIIII)GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTx
TruSeq P5 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTx
Note: Inosine is not a universal pairing base, as indicated by the decreasing stability (I·C > I·A > I·T ≈ I· G > I·I), it is most stable in a G-C base pair. However it does offer advantages over a N degenerate base, especially with longer indices.
Norman E. Watkins, Jr and John SantaLucia, JrNucleic Acids Res. 2005; 33(19): 6258–6267
In addition to Inosine, the blockers have proprietary changes made which improve performance.
Performance of xGen® Blocking Oligos with an 11,000 probe capture set
25
The IDT xGen LockdownTM Cancer Panel bait set (264 genes, 11,738 probes, 1.2 Mbp coverage) was used to enrich 4 independent libraries with unique index adaptors. The libraries were mixed and capture was performed in a multiplex hybridization reaction
with standard 48 hour hybridization.
Improved depth of coverage using xGen® Blocking Oligos
26
The IDT xGen LockdownTM Cancer Panel bait set was used to enrich 4 independent libraries with unique index adaptors. The libraries were mixed and capture was
performed in a multiplex hybridization reaction with standard 48 hour hybridization.
New rapid 4 hour hybridization/capture reaction
27
The IDT xGen LockdownTM Cancer Panel bait set was used to enrich 4 independent libraries with unique index adaptors. The libraries were
mixed and capture was performed in a multiplex hybridization reaction using new buffers and protocols with only a 4 hour hybridization step.
Benefits of the new blockers: Foundation Medicine
28
Standard blockers and new IDT xGen® Blocking Oligos were compared in an exon capture experiment using a focused set covering ~2Mb
StandardStandard Blockers xGen® Blocking Oligos
Foundation MedicineBoston, Massachusetts
Benefits of the new blockers: Washington University
29
Standard blockers and new IDT xGen® Blocking Oligos were compared in an exon capture experiment using a NimbleGen whole exome array (44Mb)
The Genome Institute, Washington UniversitySt. Louis, Missouri, USA
UnMod #1 Mod #2 Mod #3 Mod #4UnmodStandardBlockers
xGen® Blocking Oligos
Thanks to all the scientists who contributed to these studies!
30
Foundation MedicineMirna JaroszZac ZwirkoMichele Nahas
The Genome InstituteWashington UniversityElaine MardisBob FultonVince MagriniRyan Demeter
Integrated DNA TechnologiesScott RoseAshley DvorakKatie PoppBailey ClarkStephen GroenewoldRichard Owczarzy
LockdownTM Probe Technology Development Group
31
Ashley DvorakBailey Clark Katie Popp